AMEX · Analyst Forecast

Theriva Biologics, Inc. (TOVX) Stock Forecast & Price Target

$0.14 AMEX: TOVX Market Cap $6.42M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Theriva Biologics, Inc. (TOVX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Theriva Biologics, Inc., analysts forecast revenue rising from $300,000 in 2025 to $154.40M in 2030; the average estimate for 2030 earnings per share is −$0.44; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$300,000$300,000$300,0001
2026$300,000$300,000$300,0001
2027$0$0$01
2028$25.73M$25.73M$25.73M1
2029$54.05M$54.05M$54.05M1
2030$154.40M$154.40M$154.40M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.92−$2.92−$2.921
2026−$0.25−$0.25−$0.251
2027−$0.20−$0.20−$0.201
2028−$0.32−$0.32−$0.321
2029−$0.38−$0.38−$0.381
2030−$0.44−$0.44−$0.441

Theriva Biologics, Inc. (TOVX) forecast — frequently asked questions

What are analysts forecasting for Theriva Biologics, Inc.'s earnings?

The average analyst estimate for Theriva Biologics, Inc. (TOVX) earnings per share in 2030 is -0.44, with individual estimates between -0.44 and -0.44.

How much revenue is Theriva Biologics, Inc. expected to make?

Analysts forecast Theriva Biologics, Inc. (TOVX) revenue of $154.40M in 2030, based on 1 published estimates.

How many analysts cover TOVX?

1 analyst contribute estimates for Theriva Biologics, Inc. (TOVX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.